Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Advertising & Marketing

Sales

Legal & Regulatory

Acquisition & Integration

Goodwill impairment

Restructuring costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Teladoc

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company was founded on June 13, 2002, by George Byron Brooks and Gary Wald and is headquartered in Purchase, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Teladoc reports solid Q4 growth, eyes revenue optimization strategies

Teladoc's Q4 performance showed revenue growth and margin focus, with BetterHelp contributing significantly to profitability.
The company's strategic focus on virtual care expansion and revenue optimization positions Teladoc for continued success in the healthcare market.
While facing internal restructuring challenges, Teladoc's emphasis on growth drivers and operational efficiency presents opportunities for future growth and market leadership.

Teladoc Health excels in Q1, eyes growth and efficiency

Teladoc Health's Q1 performance was strong, with revenue exceeding expectations.
The company is focused on efficiency, innovation, and driving value in virtual care.
BetterHelp segment showed growth and stability, with improving margins expected.
Opportunities exist to capitalize on ad pricing stability and consumer behavior trends.

Teladoc surpasses revenue expectations, focuses on innovation and growth

Teladoc's Q2 performance exceeded expectations, with strong revenue growth and improved margins in both segments. The company's strategic focus on whole-person care, weight management, and AI enhancements positions it well for future growth. Challenges include managing drug costs and private company valuations, while opportunities lie in virtual care demand and strategic M&A.
Teladoc's financial strength, commitment to innovation, and focus on efficiency improvements are key strengths driving its performance. The company's ability to navigate challenges and capitalize on opportunities in the evolving healthcare landscape underscores its resilience and growth potential.

Teladoc Health surpasses Q3 expectations, eyes margin expansion in '24

Teladoc Health's Q3 performance exceeded expectations, driven by revenue growth and margin improvements.
The company is focused on enhancing cost efficiencies, profitability, and driving margin expansion.
Stable pricing environment and strong client demand present opportunities for future growth.
Operational review and strategic initiatives position Teladoc for continued success in the healthcare sector.

Teladoc reports robust 2023 earnings, eyes growth amid marketing challenges

Teladoc delivered strong financial performance in 2023 with notable growth in adjusted EBITDA and revenue. The company faces challenges in BetterHelp marketing yields and delayed consumer engagement efforts.
However, Teladoc's strategic strengths lie in its long-term outlook for revenue growth, margin expansion, and cost-saving initiatives. Opportunities exist in optimizing sales force structure and capital deployment for future growth.
Overall, Teladoc's focus on profitability, growth optimization, and strategic capital allocation positions it well for sustained success in the telehealth industry.

Teladoc Health reports solid Q1 performance amidst revenue challenges

Teladoc Health's Q1 2024 performance showcased revenue growth in Integrated Care but challenges in BetterHelp segment revenue and margin management.
The company's financial strength, product portfolio, and cost initiatives position it well for growth opportunities and strategic market positioning.
Addressing challenges in ad spend management and focusing on international market efficiency are key to unlocking growth potential and improving financial performance.
Overall, Teladoc's performance, strengths, challenges, and opportunities reflect a dynamic landscape with strategic focus on sustainable growth and operational efficiency.

Teladoc Health reports Q2 revenue dip, EBITDA growth; addresses challenges

Teladoc Health's Q2 2024 performance showed mixed results with revenue decline but EBITDA growth. The company is leveraging strengths in patient safety and technology while addressing challenges in customer acquisition costs. Opportunities lie in operational efficiency, insurance coverage access, and international expansion.

Teladoc Health reports Q3 revenue decline but strategic growth

Teladoc Health's Q3 2024 performance reflects mixed results with revenue decline but strategic growth in the Integrated Care segment.
The company's focus on customer-centric strategies, technology, and clinical excellence positions it well for future success and market leadership.
Challenges in revenue decline and expense management require Teladoc Health to balance short-term financial performance with long-term growth objectives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002, by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in Purchase, NY.

AMC Entertainment

Aterian

DoorDash

Royal Caribbean Cruises

Uber

Zomedica

It's the time of the year when it's just as important to identify which stocks to sell as it is to know which ones to buy. The post 7 Stocks to Sell Now to Lock in Profits While You Still Can appeared first on InvestorPlace.

7 Stocks to Sell Now to Lock in Profits While You Still Can

Apple

Delta Air Lines

September has conspired against overzealous bulls, but today there are stocks to buy with improved odds for investing success. The post 3 September Selloff Stocks to Buy appeared first on InvestorPlace.

3 September Selloff Stocks to Buy

Chewy

Disney

DraftKings

FuboTV

Roku

Zoom Video

Stocks are falling in September after seven straight months of gains. Don't panic.

My Top 7 Stocks to Buy in September's Stock Market Sell-Off

A couple of the ARK Invest exchange-traded funds run by ETF star Cathie Wood made a huge purchase on Tuesday.

Cathie Wood's ARK Invest Buys Nearly 190,000 Shares of Teladoc

Pubmatic

Trulieve Cannabis Corp.

These innovative growth stocks shouldn't be trading at a discount.

These 3 Top Stocks Have Been Halved, and It Makes No Sense

The telehealth leader's shares tumbled much further than the broad market indexes on Monday.

September Sell-Off: Is Teladoc Health a Buy While It's Down?

Teladoc seeks to be the first to offer whole person virtual multi-product and multi-specialty across the entire health care system.

Is Teladoc Buy Or Sell Now? Its Undervaluation Makes It A Strong Buy

Why Shares of Teladoc Health Are Lower Today

General Motors

A reasonably small amount of cash can go a long way with these innovative companies.

3 No-Brainer Stocks to Invest $250 in Right Now

The virtual care stock is down more than 50% from its highs earlier this year.

Why Has Teladoc Health Stock Underperformed?

CrowdStrike

Mastercard

The answer depends on your investing style.

Should You Be Worried About a Stock Market Crash? Here's What the Data Suggests

Teladoc has fallen from grace as its growth rates fizzle out. However, this telemedicine leader has more than 85% subscription revenues, with 90% retention rates.

Teladoc: Thinking About 2022 Ahead, Why This Is Compelling

UiPath

Palantir Technologies

Shopify

Skillz

Unity Software

Per its most recent 13F filings with the Securities and Exchange Commission (SEC), Woods' ARK Invest holds big ETF positions in these seven growth stocks. The post 7 Growth Stocks Cathie Wood Is Bullish on Right Now appeared first on InvestorPlace.

7 Growth Stocks Cathie Wood Is Bullish on Right Now

Fulgent Genetics

Inari Medical

It doesn't take a lot of upfront cash to add one of these stocks to your portfolio.

3 Top Healthcare Stocks You Can Buy for $100 or Less

DexCom

Illumina

Veeva Systems

The merging of healthcare and technology is changing how we care for our bodies. It's also creating investment opportunities, such as these five medical technology stocks.

5 Medtech Stocks to Seize Major Growth

Teladoc (TDOC) closed at $139.29 in the latest trading session, marking a -1.96% move from the prior day.

Teladoc (TDOC) Stock Sinks As Market Gains: What You Should Know

Axon Enterprise

MongoDB

Trade Desk

Upstart Holdings

It doesn't take much money to own a piece of the future.

Got $1,500? These 5 Stocks Will Help You Start a Value Portfolio

MercadoLibre

Each of them is a leader in a trend that's likely to gain momentum.

3 Brilliant Growth Stocks to Buy in September

The company keeps making its virtual care offering more enticing to health systems.

Why Shares of Teladoc Are Up More Than 3% Today

Baidu

Bargains still abound, even with the stock market hitting new highs.

4 Perfect Stocks Down 50% (or More) From Their Highs to Buy Right Now

American Well Corporation

Why It Isn't Too Late to Invest in Telehealth

Joby Aviation

These tech companies are bringing innovative solutions to old industries.

2 Stocks That Are Shaping the Future of Technology

Pfizer

Signify Health

Here's why the founder and CEO of ARK Invest set her sights on these three healthcare stocks.

3 Healthcare Stocks Cathie Wood Loves Right Now

Incredible bargains can still be found, even with the stock market near a record high.

3 Growth Stocks That'll Make You Richer in September (and Beyond)

Alibaba

Alphabet

Cathie Wood's Ark Invest now holds just about 700 shares in Alibaba Group Holding (NYSE:BABA) after the money managing firm on Wednesday further reduced its exposure in the e-commerce giant. Ark Invest sold 3,626 shares — estimated to be worth about $628,313 — in Alibaba, as its shares closed 3.77% higher at $173.28 on Wednesday.

Cathie Wood Nearly Erases Alibaba Stake, Sells $3M In Google — Here's What It Bought Instead On Wednesday

News for Teladoc Stock (TDOC)